Menu
Currency
GWAS Study

A genome wide association study of chronic spontaneous urticaria risk and heterogeneity.

Chang D, Hammer C, Holweg CTJ et al.

36343773 PubMed ID
GWAS Study Type
5125 Participants
211 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CD
Chang D
HC
Hammer C
HC
Holweg CTJ
SS
Selvaraj S
RN
Rathore N
MM
McCarthy MI
YB
Yaspan BL
CD
Choy DF
Chapter II

Abstract

Summary of the research findings

Chronic spontaneous urticaria (CSU) is a dermatologic condition characterized by spontaneous, pruritic hives and/or angioedema that persists for 6 weeks or longer with no identifiable trigger. Antihistamines and second-line therapies such as omalizumab are effective for some CSU patients, but others remain symptomatic, with significant impact on quality of life. This variable response to treatment and autoantibody levels across patients highlight clinically heterogeneous subgroups.

679 European ancestry, NR ancestry cases, 4,446 European ancestry, NR ancestry controls

Chapter III

Study Statistics

Key metrics and study information

5125
Total Participants
GWAS
Study Type
No
Replicated
European, NR
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.